Middle-aged men should undergo regular screening for prostate cancer, the American Cancer Society said on Nov 12 (2026) in a major change to its guidelines.
The screening involves a simple blood test, and men at average risk of getting prostate cancer should receive that PSA (prostate-specific antigen) test every two years between the ages of 50 and 69, the organisation advised.
Men at high risk, including those with a strong family history of prostate cancer, should get yearly PSA checks and start earlier at age 45.
The guideline update marks a shift in thinking about routine blood tests for PSA.
Since 2010, the American Cancer Society has recommended that men at average risk talk with their doctors about whether and how often to get PSA tests.
PSA is a protein produced by both normal and cancerous prostate cells.
This means that a high level might signal a tumour, but could also be from a benign enlarged prostate or a temporary spike from vigorous exercise.
Prostate cancer is highly survivable if caught early, but widespread PSA testing in the past was blamed for overtreatment of slow-growing tumours and unnecessary follow-up testing in men who turned out to not have cancer.
The updated advice comes after advances in understanding how regular PSA testing can help catch prostate cancer before it spreads and becomes harder to treat, as well as how to reduce potential harms from screening, according to the cancer society.
That includes steps such as repeating a PSA test to be sure it’s really high or adding an MRI (magnetic resonance imaging) scan to help identify who needs a biopsy, as well as monitoring, rather than aggressively treating, low-risk tumours.
A prostate cancer specialist not involved with the guideline said the change will be especially helpful for primary care doctors who introduce cancer screenings to patients, but who may be less familiar with the complexities.
“This has taken ambiguity out of it. They are basically saying, ‘Do it’,” said Dr Ash Tewari, who leads the urology department at Mount Sinai’s Icahn School of Medicine in New York.
“This guideline will only make things easier for men, and hopefully, it will have more grandfathers eating dinner with their family 10 years from now.”
There still needs to be a doctor-patient conversation about the pros and cons though, the cancer society guideline stresses.
“We want to find the right balance,” Dr Tewari agreed.
“Patients need to understand that their risk of prostate cancer differs”, which explains why the recommendations aren’t one-size-fits-all.
ALSO READ: My first urologist’s visit: What to expect
Strong family history is an important factor in deciding when to start screening and how often.
The cancer society says that means having one close relative – a father, brother or son – who was diagnosed with prostate cancer before age 65, or multiple close relatives diagnosed at any age.
That puts them in the high-risk category recommended for yearly PSA checks starting at age 45.
But if men have just one close relative with prostate cancer diagnosed after 65, they should still start screening at 45, but can go two years between testing.
How long screening should continue is another important question.
Because of the slow-growing nature of the cancer, it’s not for men of any age whose health is so poor that they aren’t expected to live another 10 years.
ALSO READ: Prostate cancer: A common male cancer that is slow to grow
For everyone else, the guideline advises talking with a doctor at age 70 about the choice to stop, saying benefits are less clear by that age.
The cancer society no longer recommends screening at age 75 – while acknowledging that particularly healthy 75- to 79-year-olds may choose to continue – and discourages it once men turn 80. – By Lauran Neergaard/AP
